Systemic Inflammatory Response Post Alemtuzumab and Low‐Dose Total Body Irradiation in Pediatric Patients With Sickle Cell Disease: A Case Series
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Rozalyn Chok, Katherine Girgulis, Robert S. Nickel, Gregory M. T. Guilcher |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Response to trametinib Monotherapy Without Hematopoietic Stem Cell Transplant in Juvenile Myelomonocytic Leukemia
by: Rozalyn Chok, et al.
Published: (2026)
by: Rozalyn Chok, et al.
Published: (2026)
Sensitivity and Specificity of a Signaling Question for Surveillance of Cognitive Functioning in Pediatric Sickle Cell Disease
by: Steven J. Hardy, et al.
Published: (2025)
by: Steven J. Hardy, et al.
Published: (2025)
Pulmonary Toxicities in Pediatric Patients Treated With Total Body Irradiation Using the Lateral Opposed Fields Technique
by: Natalie Boyce, et al.
Published: (2025)
by: Natalie Boyce, et al.
Published: (2025)
Hospitalization Through Families’ Eyes: Comparing Inpatient Care Quality for Children With Sickle Cell Disease and Cystic Fibrosis in Canada
by: Hailey M. Zwicker, et al.
Published: (2026)
by: Hailey M. Zwicker, et al.
Published: (2026)
Prevalence of Duffy Null and Its Impact on Hydroxyurea Dosing in Children With Sickle Cell Disease
by: Jill S. Menell, et al.
Published: (2025)
by: Jill S. Menell, et al.
Published: (2025)
Preliminary Validation of the Cancer Worry Scale in Pediatric Survivors of Childhood Cancer
by: K. Brooke Russell, et al.
Published: (2025)
by: K. Brooke Russell, et al.
Published: (2025)
Systemic Inflammatory Diseases in Children With Sickle Cell Disease: A French Multicenter Observational Study on Diagnostic and Therapeutic Issues
by: Caroline Vinit, et al.
Published: (2025)
by: Caroline Vinit, et al.
Published: (2025)
Insights Into the Caregiver Experience for Pediatric Patients With Sickle Cell Disease in Saudi Arabia: Demographic Profiles, Care Recipient Characteristics, and Subjective Well‐Being
by: Emad Shdaifat
Published: (2025)
by: Emad Shdaifat
Published: (2025)
Socioeconomic Status and Stroke Risk in Pediatric Sickle Cell Disease: A DISPLACE Study Secondary Analysis
by: Jeffrey G. Edwards, et al.
Published: (2025)
by: Jeffrey G. Edwards, et al.
Published: (2025)
Timeliness and Adherence to Opioid Administration Guidelines for Acute Sickle Cell Pain in Pediatric Patients: A Comparison of Pediatric and Adult Emergency Departments
by: Ibrahim Gwarzo, et al.
Published: (2026)
by: Ibrahim Gwarzo, et al.
Published: (2026)
Association of Food Insecurity With Disease‐Related Complications and Healthcare Utilization for Patients With Sickle Cell Disease
by: Sharjeel Syed, et al.
Published: (2025)
by: Sharjeel Syed, et al.
Published: (2025)
Caregiver Well‐Being and Pediatric Healthcare Utilization in Youth With Sickle Cell Disease: The Role of Caregiver and Child Factors
by: Theresa L. Kapke, et al.
Published: (2025)
by: Theresa L. Kapke, et al.
Published: (2025)
Treatment Experience Using a Micro‐Induction Buprenorphine Protocol for Chronic Pain in Pediatric Sickle Cell Disease
by: Ashwin Patel, et al.
Published: (2025)
by: Ashwin Patel, et al.
Published: (2025)
Associations Between Pain Scores and Opioid Doses With Emergency Department Disposition and Return Visit Rates in Children With Sickle Cell Disease
by: Keli D. Coleman, et al.
Published: (2025)
by: Keli D. Coleman, et al.
Published: (2025)
Sickle Cell Disease and Hemoglobin S Prevalence in Botswana
by: Setho Ruth Taboka Kgakatsi, et al.
Published: (2025)
by: Setho Ruth Taboka Kgakatsi, et al.
Published: (2025)
Does Hydroxyurea Reduce Hospital Admissions in Patients With Both Sickle Cell Disease and Dengue Fever?
by: Narcisse Elenga, et al.
Published: (2026)
by: Narcisse Elenga, et al.
Published: (2026)
CIC ‐Rearranged Sarcomas With Unusual Morphology and Molecular Features: A Case Series of Pediatric Patients
by: Lianyuan Yu, et al.
Published: (2026)
by: Lianyuan Yu, et al.
Published: (2026)
The Role of Associated Treatment Factors and Mental Health on Transition From Pediatric to Adult Care for Adolescent/Young Adults With Sickle Cell Disease
by: Caryn R. R. Rodgers, et al.
Published: (2025)
by: Caryn R. R. Rodgers, et al.
Published: (2025)
Pregnancy‐ and Disease‐Related Morbidity Among Medicaid Enrollees With Sickle Cell Disease
by: Mariam Kayle, et al.
Published: (2025)
by: Mariam Kayle, et al.
Published: (2025)
COVID‐19 Vaccine Response in Pediatric Oncology Patients
by: Brittni Kam, et al.
Published: (2025)
by: Brittni Kam, et al.
Published: (2025)
Intestinal Low‐Dose Radiation to Overcome PD‐1 Resistance in Pediatric Relapsed/Refractory Hodgkin Lymphoma
by: Shubham Sahni, et al.
Published: (2026)
by: Shubham Sahni, et al.
Published: (2026)
Relation of Adverse Childhood Experiences to Clinical and Patient‐Reported Outcomes for Adults With Sickle Cell Disease: A Registry Study
by: Marsha Treadwell, et al.
Published: (2025)
by: Marsha Treadwell, et al.
Published: (2025)
Hemoglobin Richmond Masquerading as Fetal Hemoglobin in a Child With Sickle Cell Disease: A Case Report and Review of the Literature
by: Jordyn Hollander, et al.
Published: (2025)
by: Jordyn Hollander, et al.
Published: (2025)
Prevalence and Significance of Pancreatic Iron in Transfusion‐Dependent Sickle Cell Disease
by: Akhila Vadivelan, et al.
Published: (2025)
by: Akhila Vadivelan, et al.
Published: (2025)
Medication Utilization Among Children With Sickle Cell Disease in the United States
by: Abiodun John Ologunowa, et al.
Published: (2025)
by: Abiodun John Ologunowa, et al.
Published: (2025)
The Voxelotor Effect: Decreased Affinity for New Drugs for Sickle Cell Disease?
by: Charles T. Quinn, et al.
Published: (2024)
by: Charles T. Quinn, et al.
Published: (2024)
Hydroxyurea Therapy and Sleep‐Disordered Breathing in Children With Sickle Cell Disease
by: Zachary Abramson, et al.
Published: (2025)
by: Zachary Abramson, et al.
Published: (2025)
Statewide Academic Performance of High School Students With Sickle Cell Disease
by: Andrew M. Heitzer, et al.
Published: (2025)
by: Andrew M. Heitzer, et al.
Published: (2025)
Sickle Cell Disease‐Related Stigma: Quantitative Assessment From India
by: Bontha V. Babu, et al.
Published: (2025)
by: Bontha V. Babu, et al.
Published: (2025)
Screening and Impact of Neuropathic Pain in Young Individuals With Sickle Cell Disease
by: Amira Adly, et al.
Published: (2024)
by: Amira Adly, et al.
Published: (2024)
Microphotopheresis for the Treatment of Graft‐Versus‐Host Disease in Pediatric Patients
by: Irina Kumukova, et al.
Published: (2025)
by: Irina Kumukova, et al.
Published: (2025)
Sickle Cell Disease Is an Inherent Risk for Asthma in a Sibling Comparison Study
by: Suhei C. Zuleta De Bernardis, et al.
Published: (2026)
by: Suhei C. Zuleta De Bernardis, et al.
Published: (2026)
Behavioral and Electrophysiological Assessment of Central Auditory Processing in Individuals With Sickle Cell Disease
by: Rhayane Vitória Lopes, et al.
Published: (2025)
by: Rhayane Vitória Lopes, et al.
Published: (2025)
How We Approach Contraception for Adolescents and Young Adults With Sickle Cell Disease
by: Maayan Leroy‐Melamed, et al.
Published: (2025)
by: Maayan Leroy‐Melamed, et al.
Published: (2025)
Impact of Neighborhood Disadvantage on Preventive and Acute Care Utilization in Sickle Cell Disease
by: Ashley Catanzarite, et al.
Published: (2024)
by: Ashley Catanzarite, et al.
Published: (2024)
Pediatric Malignancy in the Setting of Lynch Syndrome: A Case Series and Review of the Literature
by: Jordan Heiman, et al.
Published: (2026)
by: Jordan Heiman, et al.
Published: (2026)
Population Pharmacokinetics of Busulfan in Pediatric Patients: Optimization of a Four‐Times‐Daily Dosing Regimen Based on EBMT Recommendations
by: Zeyuan He, et al.
Published: (2025)
by: Zeyuan He, et al.
Published: (2025)
Safety and Efficacy of Romiplostim in Maintaining Chemotherapy Interval and Dose Intensity in Pediatric Patients With Solid Tumors and Chemotherapy‐Induced Thrombocytopenia
by: Erica Tonti, et al.
Published: (2026)
by: Erica Tonti, et al.
Published: (2026)
Post‐Transplant Cyclophosphamide for Graft‐Versus‐Host Disease Prophylaxis in Pediatric Stem Cell Transplantation
by: Aaron E. Fan, et al.
Published: (2025)
by: Aaron E. Fan, et al.
Published: (2025)
Clinical Practice Patterns for Discussing Hydroxyurea Initiation With Families of Children With Sickle Cell Disease
by: Aimee K. Hildenbrand, et al.
Published: (2026)
by: Aimee K. Hildenbrand, et al.
Published: (2026)
Similar Items
-
Response to trametinib Monotherapy Without Hematopoietic Stem Cell Transplant in Juvenile Myelomonocytic Leukemia
by: Rozalyn Chok, et al.
Published: (2026) -
Sensitivity and Specificity of a Signaling Question for Surveillance of Cognitive Functioning in Pediatric Sickle Cell Disease
by: Steven J. Hardy, et al.
Published: (2025) -
Pulmonary Toxicities in Pediatric Patients Treated With Total Body Irradiation Using the Lateral Opposed Fields Technique
by: Natalie Boyce, et al.
Published: (2025) -
Hospitalization Through Families’ Eyes: Comparing Inpatient Care Quality for Children With Sickle Cell Disease and Cystic Fibrosis in Canada
by: Hailey M. Zwicker, et al.
Published: (2026) -
Prevalence of Duffy Null and Its Impact on Hydroxyurea Dosing in Children With Sickle Cell Disease
by: Jill S. Menell, et al.
Published: (2025)